Bagdasian, Pamela

Bagdasian, Pamela was paid $619K by Medicaid between Oct 2019 and Dec 2024, across 8 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.

33Billing provider infoBAGDASIAN, PAMELA
PAWTUCKET, RI 02860

33aNPI1154487080assigned 12/28/2006

33bProvider typePhysician Assistant

28Total paid$619K

24GClaims13,554

24DCodes billed8

24AFirst – last monthOct 2019 – Dec 2024

Compared with peers

Next to other Physician Assistant providers in Rhode Island

Rank by total paid#5 of 215

Median peer was paid$17K

This provider vs. median36×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	118	$3K
2020	2,976	$108K
2021	5,585	$233K
2022	2,300	$125K
2023	1,646	$94K
2024incomplete	929	$56K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	47%	4,966	3,937	$288K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	30%	4,452	3,061	$184K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	22%	3,731	2,489	$135K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.4%	59	49	$9K
80076		<1%	95	93	$2K
80305		<1%	219	165	$1K
99442		<1%	18	18	$251.10
36415	Collection of venous blood by venipuncture	<1%	14	13	$45.73

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.